¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigens, surface"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • surface
    Ç¥¸é, ¸é
  • sacropelvic surface
    ¾ûÄ¡°ñ¹Ý¸é, õ°ñ°ñ¹Ý¸é
  • skin surface temperature
    ÇǺÎÇ¥¸é¿Âµµ
  • superolateral surface
    À§°¡Âʸé
  • surface tension
    Ç¥¸éÀå·Â
  • surface thermometer
    Ç¥¸é¿Âµµ°è
  • surface water
    ÁöÇ¥¼ö
  • ventral surface
    ¹èÂʸé, ¾Õ¸é
  • vestibular surface
    ¾È¶ã¸é
  • visceral surface
    ³»Àå¸é
  • wetting surface
    ½ÀÀ±Ç¥¸é
  • wound surface
    »óóǥ¸é
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • plantar surface of toes
    ¹ß°¡¶ô¹Ù´Ú
  • popliteal surface
    ¿À±Ý¸é
  • posterior articular surface
    µÚ°üÀý¸é
  • posterior articular surface for talus
    µÚ¸ñ¸»°üÀý¸é
  • posterior calcaneal articular surface
    µÚ¹ß±Á°üÀý¸é, ÈÄÁ¾°ñ°üÀý¸é(ý­ñ¢Íé Î¼ï½Øü).
  • posterior calcaneal articular surface
    µÚ¹ß²ÞÄ¡°üÀý¸é
  • posterior calcaneal articular surface
    µÚ¹ß´ÎÄáÝ¡e, ÈÄÁ¾°ñ°üÀý¸é(ý­ñ¢Íé Î¼ï½Øü). ?ÇØºÎ
  • posterior surface
    °üÀý¸é
  • posterior surface
    µÚ¸é
  • posterior surface of eyelids
    ´«²¨Ç®µÚ¸é
  • posterior surface of petrous portion
    ¹ÙÀ§µÚ¸é
  • posterior surface ³ª facies p.
    µÚ¸é, Èĸé(ý­Øü).
  • posterior surface ³ª facies p.
    µÚ¸é, Èĸé(ý­Øü).
  • pulmonary surface
    Æó¸é(øËØü).
  • pulmonary surface
    ÇãÆÄ¸é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cuboidal articular surface
    ÀÔ¹æ°ñ°üÀý¸é.
  • cuboidal articular surface
    ÀÔ¹æ°ñ °üÀý¸é(í¡Û°ÍéÎ¼ï½Øü).
  • cytoplasmic surface
    ÇüÁú¸·¼Ó¸é
  • depth resolved surface coil spectroscopy (DRESS)
    ±íÀÌ ÇØ°á Ç¥¸é ÄÚÀÏ ºÐ±¤¹ý
  • diaphragmatic surface
    Ⱦ°Ý¸·¸é
  • diaphragmatic surface
    Ⱦ°Ý¸·¸é, Ⱦ°Ý¸é.
  • diaphragmatic surface
    °¡·Î¸·¸é
  • disinfectant, surface-active
    °è¸éȰ¼º¼Òµ¶Á¦
  • distal proximal surface
    ¿ø½ÉÀÎÁ¢¸é (¡­ìäïÈØü).
  • distal surface
    ÀÚÀ¯¸é(í»ë¦Øü).
  • distal surface
    ¸ÕÂʸé
  • dorsal surface
    µî¸é
  • dorsal surface
    À½°æµî
  • dorsal surface
    ¹è¸é
  • dorsal surface
    µÚ¸é
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Gluteal surface
    º¼±â±Ù¸é
    [¿¾ ¿ë¾î] µÐ±Ù¸é
  • Buccal surface
    º¼¸é
    [¿¾ ¿ë¾î] Çù¸é
  • Mediastinal surface
    ¼¼·ÎÄ­¸é
    [¿¾ ¿ë¾î] Á¾°ÝºÎ
  • Internal surface
    ¼Ó¸é
    [¿¾ ¿ë¾î] ³»¸é
  • Dorsal surface of fingers
    ¼Õ°¡¶ôµî
    [¿¾ ¿ë¾î] ¼öÁö¹è¸é
  • Palmar surface of fingers
    ¼Õ°¡¶ô¹Ù´Ú
    [¿¾ ¿ë¾î] ¼öÁöÀå¸é
  • Carpal articular surface
    ¼Õ¸ñ°üÀý¸é
    [¿¾ ¿ë¾î] ¼ö±Ù°üÀý¸é
  • Inferolateral surface
    ¾Æ·¡°¡Âʸé
    [¿¾ ¿ë¾î] ÇÏ¿ÜÃø¸é
  • Inferior articular surface
    ¾Æ·¡°üÀý¸é
    [¿¾ ¿ë¾î] ÇϰüÀý¸é
  • Inferior surface
    ¾Æ·¡¸é
    [¿¾ ¿ë¾î] Çϸé
  • Vestibular surface
    ¾È¶ã¸é
    [¿¾ ¿ë¾î] ÀüÁ¤¸é
  • Medial surface
    ¾ÈÂʸé
    [¿¾ ¿ë¾î] ³»Ãø¸é
  • Medial surface
    ¾ÈÂʸé
    [¿¾ ¿ë¾î] ³»Ãø¿¬
  • Mesial surface
    ¾ÈÂʸé
    [¿¾ ¿ë¾î] ±Ù½É¸é
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
BSA benzenesulfonic acid; Biofeedback Society of America; bismuth-sulfite agar; bis-trimethylsilyl-aceta...
BSB body surface burned
Cs case; cell surface; cesium; cyclosporine
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
HBsAg hepatitis B surface ant,gen
HBs Ag Hepatitis B Virus surface antigen
HBs Hepatitis B surface
HBsAg Hepatitis B surface Ag
HBsAb Hepatitis B surface antibody
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • root surface cavity
    Ä¡±Ù¸é ¿Íµ¿
  • rough surface
    °ÅÄ£¸é, Á¶¸é
  • sacropelvic surface
    õ°ñ °ñ¹Ý¸é
  • scaly surface
    ºñ´Ã ¸é
  • smooth surface caries
    ÆòȰ¸é ¿ì½ÄÁõ
  • surdity : µ¿ÀǾî=deafness.

    surface

    ¸é, Ç¥¸é
  • surface anesthesia
    Ç¥¸é ¸¶Ãë, Ç¥¸é ¸¶Ãë¹ý
  • surface caries
    Ç¥¸é ¿ì½Ä
  • surface condition
    Ç¥¸é »óÅÂ
  • surface cooling
    Ç¥¸é ³Ã°¢
  • surface culture
    Ç¥¸é ¹è¾ç
  • surface drying
    Ç¥¸é °ÇÁ¶
  • surface epithelium
    Ç¥¸é »óÇÇ
  • surface hardness
    Ç¥¸é °æµµ
  • surface molecule
    Ç¥¸é¿¡ ÀÖ´Â ºÐÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
antigens, heterophile Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species.
(12 Dec 1998)
antigens, human platelet Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.
(12 Dec 1998)
antigens, ly A group of lymphocyte surface antigens differentially located on subpopulations of mouse lymphocytes. This localization has been useful in distinguishing different functional subpopulations of lymphocytes. For example, cytotoxic T-cells bear primarily lyt-23 on their surface and not lyt-1, whereas helper cells bear lyt-1 and not lyt-23.
(12 Dec 1998)
antigens, neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumour cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
(12 Dec 1998)
antigens, polyomavirus transforming Polyomavirus antigens which cause infection and cellular transformation. The large t antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle t antigen for the transformation of primary cells. Small t antigen is necessary for the completion of the productive infection cycle.
(12 Dec 1998)
antigens, protozoan Any part or derivative of any protozoan that elicits immunity; malaria (plasmodium) and trypanosome antigens are presently the most frequently encountered.
(12 Dec 1998)
antigens, thy-1 A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.
(12 Dec 1998)
antigens, t-independent Antigens which may directly stimulate b lymphocytes without the cooperation of t lymphocytes.
(12 Dec 1998)
antigens, tumour-associated, carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
(12 Dec 1998)
antigens, viral Substances elaborated by viruses that have antigenic activity.
(12 Dec 1998)
antigens, viral, tumour Those proteins recognised by antibodies from serum of animals bearing tumours induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation.
(12 Dec 1998)
CDE antigens rh blood group
CENP antigens <molecular biology> Proteins of the kinetochore (CENP A 27 kD, CENP B 80 kD, CENP C 140 kD and CENP D 50 kD) that react strongly with antibodies from CREST sera.
(18 Nov 1997)
Gm antigens Allotypic determinants (antigens) that are present on the heavy chain of immunoglobulin G. There are 25 different determinants present throughout the human population.
(05 Mar 2000)
Rh antigens rh blood group
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á